Stay updated on Ruxolitinib in COVID Cytokine Storm Clinical Trial
Sign up to get notified when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.

Latest updates to the Ruxolitinib in COVID Cytokine Storm Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision label updated to v3.5.4. This appears to be an internal site update with no visible changes to the study details.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page’s revision/version label was updated from **v3.5.2** to **v3.5.3**, reflecting a site software update rather than a change to the study information.SummaryDifference0.0%

- Check43 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0. This appears to be a minor version label update with no impact on trial details or visible content.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check79 days agoChange DetectedThe Revision label on the page was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check107 days agoChange DetectedRevision: v3.4.2 is now displayed on the page. The previous government funding lapse notice has been removed, and core study content remains unchanged.SummaryDifference0.3%

Stay in the know with updates to Ruxolitinib in COVID Cytokine Storm Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.